In addition, experimental findings using DPEO treatment on Aβ1–42-damaged SH-SY5Y cells, a cellular model of AD, demonstrated that DPEO could elevate Tau protein levels and reduce the phosphorylation of Aβ1–42 and P-Tau proteins within neuron cells to maintain normal neuronal structures. This evidence concerns the gene MAPT and Alzheimer disease.